Skip to main content
. 2021 Nov 10;13(22):5620. doi: 10.3390/cancers13225620

Figure 4.

Figure 4

Prognostic role of GSMDs in glioma. Differences in survival between high and low expression in GBM patients were analyzed using Kaplan–Meier analysis with a log-rank significance test. All data were downloaded from GlioVis and optimal cutoff determined using GlioVis. GSDMA expression data was missing in Gravendeel and Rembrandt, while the TCGA-GBM dataset lacked DFNB59 expression. HR, hazard ratio.